Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study.
- DOI
- 10.1016/j.jfma.2024.08.014
- Published
- 2025 Aug
- Container
- Journal of the Formosan Medical Association = Taiwan yi zhi
- Publisher
- Not recorded
- Open access
- no
Credibility signals
uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jfma.2024.08.014,
title = {Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study.},
author = {Wu HH and Wang PH and Chen YJ and Chao WT},
year = {2025},
journal = {Journal of the Formosan Medical Association = Taiwan yi zhi},
doi = {10.1016/j.jfma.2024.08.014},
url = {https://doi.org/10.1016/j.jfma.2024.08.014}
}RIS
TY - JOUR TI - Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study. AU - Wu HH AU - Wang PH AU - Chen YJ AU - Chao WT PY - 2025 JO - Journal of the Formosan Medical Association = Taiwan yi zhi DO - 10.1016/j.jfma.2024.08.014 UR - https://doi.org/10.1016/j.jfma.2024.08.014 ER -
APA
HH, W., PH, W., YJ, C., & WT, C. (2025). Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study.. Journal of the Formosan Medical Association = Taiwan yi zhi. https://doi.org/10.1016/j.jfma.2024.08.014
Source records
- pubmed · retrieved 2026-09-25T04:40:03.079Z
- europe-pmc · retrieved 2026-09-25T04:40:03.112Z
- doaj · retrieved 2026-09-25T04:40:03.083Z